Want to join the conversation?
$ACOR said that PTAB has not yet ruled on the petitionerâ??s previously filed motion of reconsideration of the 2 initial IPR petitions that were denied in Aug. 2015. The patents apply to AMPYRA Extended Release Tablets, 10 mg, for treating multiple sclerosis. These patents are set to expire between 2025 and 2027.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.